Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast Button Switch to Spanish Language Contact Us Sitemap Sign In Register
Link to Homepage About AHAF
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research


Sign up for Email Notifications
If you would like to be notified when submission deadlines are announced please click on the link below.

Sign up for new RFP announcements and submission deadline notifications.

This email list is not sold or distributed, and serves only as an annual reminder of the availability of research funding through the American Health Assistance Foundation (www.ahaf.org). Please follow instructions on the notification emails for removal requests.

 
AHAF Research Grants Funding
Grant Funding for Alzheimer's Research
Grant Funding for Macular Degeneration Research
Grant Funding for Glaucoma Research
 

 

Alzheimer's Disease Research - Current Award

Dr. Paul Salvaterra

Paul Salvaterra, Ph.D.

Beckman Research Institute of the City of Hope
Duarte, CA

Title: Ab and Neurodegeneration
Non-Technical Title: Ab and neurodegeneration

Duration: April 1, 2007 - March 31, 2010
Award Type: Standard
Award Amount: $400,000


Summary:

Our work is designed to investigate the role of certain peptides, both alone and in combination, as direct causes of chronic brain cell death. We will accomplish this by using a simplified genetically controlled model organism. We also believe that our preliminary observations indicate a new cellular pathway that may be responsible for Alzheimer's related cell death. We will thus try and prove this hypothesis using genetic and drug based experimental strategies in our model system.

Details:

Chronic and progressive dying neurons are the major feature of Alzheimer's disease that can best explain the clinical symptoms. More than 20 years of intensive research has implicated two toxic peptides generated from a larger normal protein as playing an important role in the disease process. It is not known, however, if these peptides are a cause of the disease or just an effect of some other problem in brain cells. Our work is designed to investigate the role of these peptides, both alone and in combination, as direct causes of chronic brain cell death. We will accomplish this by using a simplified genetically controlled model organism. We also believe that our preliminary observations indicate a new cellular pathway that may be responsible for Alzheimer's related cell death. We will thus try and prove this hypothesis using genetic and drug based experimental strategies in our model system. If this new pathway is indeed responsible for cell death in Alzheimer's disease our work could lead to the identification of new treatment and prevention strategies.